Stay updated on Adagrasib Combo in KRAS G12C Clinical Trial

Sign up to get notified when there's something new on the Adagrasib Combo in KRAS G12C Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adagrasib Combo in KRAS G12C Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A site-wide NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the study record, and the displayed site revision changes from v3.7.1 to v3.7.2. The study record itself remains a 403 error page.
    Difference
    1%
    Check dated 2026-10-20T23:39:46.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer now identifies the ClinicalTrials.gov site revision as v3.7.1 instead of v3.7.0. The page remains a 403 error page.
    Difference
    0.2%
    Check dated 2026-10-07T00:24:55.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    403 Forbidden error now appears on the page, replacing the expected study details with a generic error screen and a Home option. The study record is currently inaccessible on ClinicalTrials.gov.
    Difference
    21%
    Check dated 2026-09-23T00:09:07.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Updated the label for locating contact information from 'Find Contact Information' to 'Find contact information' to align with the page's capitalization style. The release version was bumped from v3.6.6 to v3.7.0.
    Difference
    0.0%
    Check dated 2026-09-15T22:43:49.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page revision label updated from v3.6.5 to v3.6.6. This change is a backend revision with no impact on the visible study details.
    Difference
    0.0%
    Check dated 2026-09-01T20:59:01.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    New recruitment sites and investigators were added to the study record, expanding listed locations and contacts. An NIH grant/contract entry was added, and an existing investigator entry was removed.
    Difference
    0.1%
    Check dated 2026-08-25T23:22:00.000Z thumbnail image

Stay in the know with updates to Adagrasib Combo in KRAS G12C Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adagrasib Combo in KRAS G12C Clinical Trial page.